160 related articles for article (PubMed ID: 22948997)
1. Intravitreal dobesilate in the treatment of choroidal neovascularisation associated with age-related macular degeneration: report of two cases.
Cuevas P; Outeiriño L; Azanza C; Giménez-Gallego G
BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 22948997
[TBL] [Abstract][Full Text] [Related]
2. Treatment of dry age-related macular degeneration with dobesilate.
Cuevas P; Outeiriño LA; Angulo J; Giménez-Gallego G
BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22729337
[TBL] [Abstract][Full Text] [Related]
3. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Stargardt disease with dobesilate.
Cuevas P; Outeiriño LA; Angulo J; Giménez-Gallego G
BMJ Case Rep; 2012 Oct; 2012():. PubMed ID: 23076703
[TBL] [Abstract][Full Text] [Related]
5. The effect of intravitreal administration of bevacizumab on macular edema and visual acuity in age-related macular degeneration with subfoveolar choroidal neovascularisation.
Ristić D; Vukosavljević M; Draganić B; Cerović V; Petrović N; Janićijević-Petrović M
Vojnosanit Pregl; 2013 Jul; 70(7):660-3. PubMed ID: 23984614
[TBL] [Abstract][Full Text] [Related]
6. The short-term effects of aflibercept on the size of choroidal neovascularization lesion in treatment-resistant neovascular age-related macular degeneration as determined by spectral-domain optical coherence tomography.
Abri Aghdam K; Seidensticker F; Pielen A; Framme C; Junker B
Lasers Surg Med; 2016 Sep; 48(7):668-77. PubMed ID: 27111455
[TBL] [Abstract][Full Text] [Related]
7. One-year outcomes of less frequent bevacizumab in age-related macular degeneration.
Sonmez K; Sonmez PA; Ozkan SS; Atmaca LS
Retina; 2011 Apr; 31(4):645-53. PubMed ID: 21358363
[TBL] [Abstract][Full Text] [Related]
8. Durable recovery of the macular architecture and functionality of a diagnosed age-related macular degeneration 1 year after a single intravitreal injection of dobesilate.
Cuevas P; Outeiriño LA; Azanza C; Giménez-Gallego G
BMJ Case Rep; 2013 Nov; 2013():. PubMed ID: 24225910
[TBL] [Abstract][Full Text] [Related]
9. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration.
Kaiser PK; Blodi BA; Shapiro H; Acharya NR;
Ophthalmology; 2007 Oct; 114(10):1868-75. PubMed ID: 17628683
[TBL] [Abstract][Full Text] [Related]
10. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
Rosenfeld PJ; Moshfeghi AA; Puliafito CA
Ophthalmic Surg Lasers Imaging; 2005; 36(4):331-5. PubMed ID: 16156152
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of choroidal neovascularization with indocyanine green angiography in neovascular age-related macular degeneration subjects undergoing intravitreal bevacizumab therapy.
Rush RB; Rush SW; Aragon AV; Ysasaga JE
Am J Ophthalmol; 2014 Aug; 158(2):337-44. PubMed ID: 24844972
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
Retina; 2007; 27(4):432-8. PubMed ID: 17420694
[TBL] [Abstract][Full Text] [Related]
13. Small dense particles in the retina observable by spectral-domain optical coherence tomography in age-related macular degeneration.
Framme C; Wolf S; Wolf-Schnurrbusch U
Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5965-9. PubMed ID: 20574019
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration.
Ach T; Hoeh AE; Ruppenstein M; Kretz FT; Dithmar S
Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764
[TBL] [Abstract][Full Text] [Related]
15. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
[TBL] [Abstract][Full Text] [Related]
16. Chronic cystoid macular oedema treated with intravitreal dobesilate.
Cuevas P; Outeiriño LA; Angulo J; Giménez-Gallego G
BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22778475
[TBL] [Abstract][Full Text] [Related]
17. Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration.
Lazic R; Gabric N
Graefes Arch Clin Exp Ophthalmol; 2007 Jan; 245(1):68-73. PubMed ID: 17111146
[TBL] [Abstract][Full Text] [Related]
18. Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab.
Stangos AN; Gandhi JS; Nair-Sahni J; Heimann H; Pournaras CJ; Harding SP
Am J Ophthalmol; 2010 Nov; 150(5):666-73. PubMed ID: 20719300
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration.
Matsumoto H; Hiroe T; Morimoto M; Mimura K; Ito A; Akiyama H
Jpn J Ophthalmol; 2018 Mar; 62(2):144-150. PubMed ID: 29411171
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab for treatment-naive patients with subfoveal occult choroidal neovascularization secondary to age-related macular degeneration: a 12-month follow-up study.
Costagliola C; Romano M; Corte MD; Perrotta R; Menzione M; Rinaldi M; Semeraro F; Parmeggiani F
Retina; 2009 Oct; 29(9):1227-34. PubMed ID: 19934817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
